News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,071 Results
Type
Article (42353)
Company Profile (294)
Press Release (673424)
Section
Business (210386)
Career Advice (2091)
Deals (36627)
Drug Delivery (106)
Drug Development (83024)
Employer Resources (175)
FDA (16552)
Job Trends (15396)
News (355929)
Policy (33885)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2591)
Accelerated approval (4)
Adcomms (21)
Allergies (84)
Alliances (51381)
ALS (87)
Alzheimer's disease (1377)
Antibody-drug conjugate (ADC) (117)
Approvals (16555)
Artificial intelligence (249)
Autoimmune disease (18)
Automation (14)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (188)
Bladder cancer (58)
Brain cancer (27)
Breast cancer (255)
Cancer (2053)
Cardiovascular disease (171)
Career advice (1749)
Career pathing (30)
CAR-T (142)
Cell therapy (404)
Cervical cancer (19)
Clinical research (67291)
Collaboration (790)
Compensation (472)
Complete response letters (25)
COVID-19 (2653)
CRISPR (41)
C-suite (217)
Cystic fibrosis (101)
Data (1998)
Decentralized trials (2)
Denatured (26)
Depression (41)
Diabetes (253)
Diagnostics (6422)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (116)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (86)
Earnings (87918)
Editorial (33)
Employer branding (21)
Employer resources (149)
Events (114587)
Executive appointments (664)
FDA (17695)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (702)
Gene editing (104)
Generative AI (20)
Gene therapy (294)
GLP-1 (724)
Government (4503)
Grass and pollen (4)
Guidances (49)
Healthcare (18992)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (113)
Indications (27)
Infectious disease (2786)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (89)
Interviews (322)
IPO (16764)
IRA (47)
Job creations (4055)
Job search strategy (1492)
Kidney cancer (9)
Labor market (34)
Layoffs (477)
Leadership (16)
Legal (8369)
Liver cancer (71)
Lung cancer (295)
Lymphoma (136)
Machine learning (4)
Management (59)
Manufacturing (281)
MASH (63)
Medical device (13412)
Medtech (13417)
Mergers & acquisitions (20339)
Metabolic disorders (654)
Multiple sclerosis (72)
NASH (17)
Neurodegenerative disease (85)
Neuropsychiatric disorders (26)
Neuroscience (1880)
NextGen: Class of 2025 (6637)
Non-profit (4524)
Northern California (2467)
Now hiring (37)
Obesity (354)
Opinion (226)
Ovarian cancer (73)
Pain (88)
Pancreatic cancer (77)
Parkinson's disease (139)
Partnered (20)
Patents (210)
Patient recruitment (98)
Peanut (49)
People (59080)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20866)
Phase II (29603)
Phase III (22199)
Pipeline (1069)
Podcasts (75)
Policy (125)
Postmarket research (2654)
Preclinical (8843)
Press Release (68)
Prostate cancer (95)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (376)
Real estate (6252)
Recruiting (67)
Regulatory (23015)
Reports (46)
Research institute (2367)
Resumes & cover letters (358)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (72)
Series A (124)
Series B (79)
Service/supplier (12)
Sickle cell disease (54)
Southern California (2128)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3721)
State (2)
Stomach cancer (14)
Supply chain (61)
Tariffs (13)
The Weekly (47)
United States (21553)
Vaccines (677)
Venture capitalists (37)
Webinars (12)
Weight loss (241)
Women's health (33)
Worklife (15)
Date
Today (101)
Last 7 days (674)
Last 30 days (2681)
Last 365 days (34038)
2025 (8404)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (781)
Alabama (49)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (40594)
Australia (6504)
California (5614)
Canada (1891)
China (488)
Colorado (250)
Connecticut (257)
Delaware (131)
Europe (86568)
Florida (831)
Georgia (196)
Idaho (57)
Illinois (513)
India (25)
Indiana (301)
Iowa (9)
Japan (147)
Kansas (101)
Kentucky (23)
Louisiana (8)
Maine (61)
Maryland (842)
Massachusetts (4260)
Michigan (211)
Minnesota (373)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1608)
New Mexico (29)
New York (1610)
North Carolina (943)
North Dakota (7)
Northern California (2467)
Ohio (192)
Oklahoma (14)
Oregon (38)
Pennsylvania (1270)
Puerto Rico (9)
Rhode Island (27)
South America (1160)
South Carolina (18)
South Dakota (1)
Southern California (2128)
Tennessee (95)
Texas (842)
Utah (166)
Virginia (138)
Washington D.C. (57)
Washington State (523)
West Virginia (3)
Wisconsin (51)
716,071 Results for "astex pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Astex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Research (AACR) 2024 Annual Meeting
Astex Pharmaceuticals announced that it will make five key data presentations at AACR 2024 focusing on its Phase II-ready MDM2 antagonist, ASTX295.
April 3, 2024
·
3 min read
Press Releases
Astex Pharmaceuticals Announce Key Data Presentations at the 36th EORTC-NCI-AACR Symposium
October 21, 2024
·
4 min read
Biotech Bay
Taiho Oncology and Astex Pharmaceuticals Announce Data Presentations at the 65th ASH Annual Meeting
Taiho Oncology Inc. and Astex Pharmaceuticals, Inc. announced today details of studies to be presented at the 65th American Society of Hematology (ASH) Annual Meeting, to be held Dec. 9-12, 2023, in San Diego.
November 17, 2023
·
5 min read
Genetown
Astex Expands Drug Discovery Collaboration With MSD
Astex Pharmaceuticals announced an exclusive worldwide research collaboration and license agreement with MSD.
August 8, 2023
·
2 min read
Policy
Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia
Otsuka Pharmaceutical Europe Ltd. and Astex Pharmaceuticals, Inc. announce that the European Commission has approved INAQOVI® as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia who are ineligible for standard induction chemotherapy.
September 19, 2023
·
7 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
Business
Third Success from Astex Drug Discovery Pharma Collaboration and Licence Agreements as AstraZeneca Receives US Marketing Approval for Cancer Drug Truqap (capivasertib)
Astex Pharmaceuticals announced that it is in line to receive a milestone payment from AstraZeneca on first commercial sale of the drug in the US and royalties from AstraZeneca on future sales following the US Food and Drug Administration’s approval of Truqap™ plus Faslodex® as a treatment for adult patients with HR-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker alterations.
November 20, 2023
·
4 min read
Press Releases
CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
March 25, 2025
·
4 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE
April 3, 2025
·
5 min read
Press Releases
Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering
March 10, 2025
·
6 min read
1 of 71,608
Next
